Abnormal levels of cAMP-dependent protein kinase regulatory subunits in platelets from schizophrenic patients

Daniela Tardito, Gian Battista Tura, Luisella Bocchio, Stefano Bignotti, Rosaria Pioli, Giorgio Racagni, Jorge Perez

Research output: Contribution to journalArticle

Abstract

Abnormalities in the cAMP-dependent protein kinase (PKA), a central component of cAMP signaling, have been reported in several psychiatric disorders. Previous studies showed cAMP signaling alterations in schizophrenic patients but less is known about the involvement of PKA in such disorder. Therefore, we investigated the PKA subunits by Western blot analysis in platelets from 12 patients with schizophrenia and 13 controls. The results showed that the immunolabeling of the PKA regulatory subunits type I (RI) and type II (RII) was significantly reduced in patients compared with controls whereas no differences were observed in the catalytic (C) subunit of the enzyme. These preliminary data suggest that schizoprenic patients have altered PKA levels, thus supporting that dysfunctions in the components of cAMP signaling may contribute to the pathophysiology of schizophrenia. Copyright (C) 2000 American College of Neuropsychopharmacology.

Original languageEnglish
Pages (from-to)216-219
Number of pages4
JournalNeuropsychopharmacology
Volume23
Issue number2
DOIs
Publication statusPublished - Aug 2000

    Fingerprint

Keywords

  • cAMP-dependent protein kinase
  • Platelets
  • Schizophrenia

ASJC Scopus subject areas

  • Pharmacology

Cite this